UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1849-1861.e13

2019

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia

Current opinion in oncology, 2022-09, Vol.34 (5), p.531

2022

Link zum Volltext

Verfügbarkeit prüfen

High-Risk Mantle Cell Lymphoma in the Era of Novel Agents

Current hematologic malignancy reports, 2021-02, Vol.16 (1), p.8-18

2021

Link zum Volltext

Verfügbarkeit prüfen

GATA3 rs3824662A allele in B‐cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis

American journal of hematology, 2021-03, Vol.96 (3), p.E71-E74

2021

Link zum Volltext

Verfügbarkeit prüfen

A Clinical Review of the Different Strategies to Minimize Hemorrhagic Cystitis Associated with the Use of Post-Transplantation Cyclophosphamide in an Allogeneic Transplant

Transplantation and cellular therapy, 2022-07, Vol.28 (7), p.349-354

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity

International journal of biological sciences, 2023-01, Vol.19 (14), p.4644-4656

2023

Link zum Volltext

Verfügbarkeit prüfen

Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship

Cancer, 2017-02, Vol.123 (4), p.609-616

2017

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma

American journal of cancer research, 2020-01, Vol.10 (2), p.564-571

2020

Link zum Volltext

Verfügbarkeit prüfen

ASC2ESCALATE: A US phase 2, single-arm, dose-escalation study of asciminib monotherapy in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with 1 prior tyrosine kinase inhibitor (TKI)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS7082-TPS7082

2023

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Results from a Phase 2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine or Decitabine in Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (TWT-202)

Blood, 2022-11, Vol.140 (Supplement 1), p.9076-9077

2022

Link zum Volltext

Verfügbarkeit prüfen

ASC2ESCALATE: A Phase 2, Single-Arm, Dose-Escalation Study of Asciminib Monotherapy in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with 1 Prior Tyrosine Kinase Inhibitor (TKI)

Blood, 2022-11, Vol.140 (Supplement 1), p.6784-6786

2022

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1a/b Dose Escalation Study of the FLT3/BTK Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.6220-6221

2022

Link zum Volltext

Verfügbarkeit prüfen

Olverembatinib (HQP1351) Overcomes Ponatinib Resistance in Patients with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Blood, 2022-11, Vol.140 (Supplement 1), p.200-202

2022

Link zum Volltext

Verfügbarkeit prüfen

Tocilizumab for the Management of Cytokine Release Syndrome after Haploidentical Hematopoietic Transplant with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Blood, 2022-11, Vol.140 (Supplement 1), p.7580-7582

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of the GATA3 rs3824662A allele with clinical outcomes in adult patients with adult B-ALL

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.7023-7023

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1

Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia

High-Risk Mantle Cell Lymphoma in the Era of Novel Agents

GATA3 rs3824662A allele in B‐cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis

A Clinical Review of the Different Strategies to Minimize Hemorrhagic Cystitis Associated with the Use of Post-Transplantation Cyclophosphamide in an Allogeneic Transplant

Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity

Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship

Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma

ASC2ESCALATE: A US phase 2, single-arm, dose-escalation study of asciminib monotherapy in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with 1 prior tyrosine kinase inhibitor (TKI)

ASC2ESCALATE: A Phase 2, Single-Arm, Dose-Escalation Study of Asciminib Monotherapy in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with 1 Prior Tyrosine Kinase Inhibitor (TKI)

A Phase 1a/b Dose Escalation Study of the FLT3/BTK Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Renal Impairment Adversely Impacts Melphalan-Induced Severe GvHD- and GI Toxicity- Free Survival (MGTFS) in Patients Undergoing Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation

Outcomes Post-Allogeneic Hematopoietic Cell Transplantation Relapse in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Olverembatinib (HQP1351) Overcomes Ponatinib Resistance in Patients with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Long Term Outcomes of Patients with Chronic Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation in the Era of Oral Tyrosine Kinase Inhibitors

Tocilizumab for the Management of Cytokine Release Syndrome after Haploidentical Hematopoietic Transplant with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Sinusoidal Obstruction Syndrome in Adult Patients with B-Cell Acute Lymphoblastic Leukemia Treated with Inotuzumab Prior to Hematopoietic Stem Cell Transplantation

Phase IIa Study of Adding Itacitinib to Tacrolimus/Sirolimus Gvhd Prophylaxis after Fludarabine/Melphalan-Based Conditioning Hematopoietic Cell Transplantation for Acute Leukemias, Myelodysplastic Syndrome, or Myelofibrosis

Challenges of Maintenance Tyrosine Kinase Inhibitor Therapy after Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Myeloablative Vs Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation in Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

Outcome of Patients Undergoing Hematopoietic Cell Transplantation for TP53-Mutated Acute Leukemias and MDS: Effect of Conditioning and GvHD Prophylaxis Regimens Intensity

Association of the GATA3 rs3824662A allele with clinical outcomes in adult patients with adult B-ALL

Evaluation of 5-Day Vs. 10-Day Decitabine in Combination with Venetoclax in Newly Diagnosed AML Patients Ineligible for Induction Chemotherapy

Novel Salvage Therapies Are Highly Effective in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) with Philadelphia (Ph)-like Fusions

Suchergebnisse filtern